|
Originally published In Press as doi:10.1074/jbc.M202107200 on April 17, 2002
J. Biol. Chem., Vol. 277, Issue 26, 23807-23814, June 28, 2002
Structure and Function of Human Erythrocyte Pyruvate
Kinase
MOLECULAR BASIS OF NONSPHEROCYTIC HEMOLYTIC ANEMIA*
Giovanna
Valentini §¶,
Laurent R.
Chiarelli§,
Riccardo
Fortin ,
Manuela
Dolzan ,
Alessandro
Galizzi ,
Donald J.
Abraham ,
Changqing
Wang ,
Paola
Bianchi**,
Alberto
Zanella**, and
Andrea
Mattevi 
From the Dipartimento di Genetica e Microbiologia,
Università di Pavia, via Abbiategrasso 207, 27100 Pavia, Italy,
the § Dipartimento di Biochimica, Università di Pavia,
via Taramelli 3b, 27100 Pavia, Italy, the Department of
Medicinal Chemistry, Virginia Commonwealth University, Richmond,
Virginia 23219, and the ** Divisione di Ematologia, IRCCS
Ospedale Maggiore di Milano, via Francesco Sforza 35, 20122 Milano, Italy
Deficiency of human erythrocyte isozyme (RPK) is,
together with glucose-6-phosphate dehydrogenase deficiency, the most
common cause of the nonspherocytic hemolytic anemia. To provide a
molecular framework to the disease, we have solved the 2.7 Å resolution crystal structure of human RPK in complex with fructose
1,6-bisphosphate, the allosteric activator, and phosphoglycolate, a
substrate analogue, and we have functionally and structurally
characterized eight mutants (G332S, G364D, T384M, D390N, R479H, R486W,
R504L, and R532W) found in RPK-deficient patients. The mutations target
distinct regions of RPK structure, including domain interfaces and
catalytic and allosteric sites. The mutations affect to a different
extent thermostability, catalytic efficiency, and regulatory
properties. These studies are the first to correlate the clinical
symptoms with the molecular properties of the mutant enzymes. Mutations greatly impairing thermostability and/or activity are associated with
severe anemia. Some mutant proteins exhibit moderate changes in the
kinetic parameters, which are sufficient to cause mild to severe
anemia, underlining the crucial role of RPK for erythrocyte metabolism.
Prediction of the effects of mutations is difficult because there is no
relation between the nature and location of the replaced amino acid and
the type of molecular perturbation. Characterization of mutant proteins
may serve as a valuable tool to assist with diagnosis and genetic counseling.
*
This work was supported by grants from University of Pavia
Progetto d'Ateneo "Nuove Tecnologie Molecolari e Cellulari,"
Ministero della Ricerca Scientifica e Tecnologica Progetto Genomica
Funzionale, and Allos Therapeutics Inc. (Westminster, CO).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The atomic coordinates and the structure factors (code 1LIU, 1LIW, 1LIX, and 1LIY) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
¶
To whom correspondence may be addressed. Fax: 39-0382-423108;
E-mail: giovale@unipv.it.

To whom correspondence may be addressed. Fax: 39-0382-528496;
E-mail: mattevi@ipvgen.unipv.it.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Zanella, P. Bianchi, and E. Fermo
Pyruvate kinase deficiency
Haematologica,
June 1, 2007;
92(6):
721 - 723.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. van Wijk and W. W. van Solinge
The energy-less red blood cell is lost: erythrocyte enzyme abnormalities of glycolysis
Blood,
December 15, 2005;
106(13):
4034 - 4042.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Diez, F. Gilsanz, J. Martinez, S. Perez-Benavente, N. W. Meza, and J. M. Bautista
Life-threatening nonspherocytic hemolytic anemia in a patient with a null mutation in the PKLR gene and no compensatory PKM gene expression
Blood,
September 1, 2005;
106(5):
1851 - 1856.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. R. Chiarelli, P. Bianchi, E. Fermo, A. Galizzi, P. Iadarola, A. Mattevi, A. Zanella, and G. Valentini
Functional analysis of pyrimidine 5'-nucleotidase mutants causing nonspherocytic hemolytic anemia
Blood,
April 15, 2005;
105(8):
3340 - 3345.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|